𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Study of endothelial dysfunction and its correlation with disease activity in systemic lupus erythematosus patients without conventional cardiovascular risk factors

✍ Scribed by Apurba Bikash Pramanik; Kuntal Bhattacharyya; Pradip Kumar Sinha; Rathindra Nath Sarkar; Rudrajit Paul; Runa Das; Siddhartha Mani; Raja Bhattacharya

Book ID
117689582
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
128 KB
Volume
6
Category
Article
ISSN
0973-3698

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of conventional and lupus-spe
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case–control study
✍ Bessant, Rupa ;Duncan, Rachel ;Ambler, Gareth ;Swanton, Jo ;Isenberg, David A. ; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov

Systemic lupus erythematosus in a multie
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
✍ Jaime Calvo-AlΓ©n; Sergio M. A. Toloza; MΓ³nica FernΓ‘ndez; Holly M. Bastian; Barri πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a